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Dear Editor,
With widespread PSA screening, the number of equivo-
cal cases of prostate cancer has dramatically increased. This
has led to a concomitant increase in the number of prostate
biopsies, many of which might be deemed unnecessary.
Prostate biopsy is an invasive procedure, fraught with
potential complications. A non-invasive alternative would
certainly be preferable.
Dr. Eric SchiVer has reviewed the many prostate cancer
biomarkers and their impact on the clinical management of
this disease [1]. These biomarkers utilize blood, tissue,
urine, and seminal Xuid assays. He posits that both urine
and seminal Xuid may detect early prostate malignancy
through exfoliated cancer cells and secreted prostate prod-
ucts. Urine may also be a potential source of prostate-spe-
ciWc markers. However, since a signiWcant volume of
seminal Xuid is produced by the prostate and seminal vesi-
cles, seminal Xuid might be an even better choice for this
purpose. Cytological examination of the seminal Xuid may
be able to provide a more direct method of revealing an
underlying prostate and/or seminal vesicle malignancy and
serve as an alternative to prostate biopsy.
DiVerentiating prostate from other epithelial cells could
present a problem for the cytologist. However, some inves-
tigators have reported having done so using special staining
techniques [2, 3]. The use of semen cytology could not only
evolve into a feasible method for identifying the tumor cells
but also be able to ascertain the grade of the underlying
tumor.
In order to establish the validity of using semen cytology
as a method for diagnosing prostate carcinoma, one must
Wrst Wnd answers to the following questions:
1. If the cancer cells found in a semen specimen are com-
parable to the cells from multiple biopsy specimens?
(Taking into account that some of the prostate tissue
may no longer be connected to the ductal system and
might, therefore, not shed cells into the ejaculate.)
2. What % of patients with low-grade prostate cancer has
cancer cells in their semen?
3. What % of patients with a high-grade tumor and/or
seminal vesicle invasion has cancer cells in their
semen?
4. If the levels of PSA, PCA3 (and possibly other tumor
markers as well) correlate positively with the biopsy
and cytology results?
5. What are the Wndings in a control group?
There is a real need for a less invasive diagnostic procedure
than prostate biopsy. Furthermore, if prostate malignancy is
found, it is important to diVerentiate between the men with
aggressive tumors from those with slow growing tumors
which may present no clinical problems.
I am hoping that these comments will stimulate a more
thorough study to ascertain if semen cytology can be used
as an alternative for prostate biopsy.
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